Outset Medical, Inc. provided revenue guidance for the full year 2023. for the year, the company expects revenue guidance range of $144 million to $150 million, and now expects to be at the low end of this range as a result of the shipment pause for TabloCart with Prefiltration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 USD | +6.39% | +22.32% | -19.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.96% | 211M | |
+9.24% | 220B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.17B | |
+14.99% | 52.47B | |
+4.85% | 50.77B | |
-4.47% | 38.97B | |
-0.41% | 35.13B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Provides Revenue Guidance for the Full Year 2023